Y-mAbs Therapeutics Files 8-K on Shareholder Vote Matters
| Field | Detail |
|---|---|
| Company | Y-Mabs Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Jul 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Y-mAbs held a shareholder vote; details to follow.
AI Summary
Y-mAbs Therapeutics, Inc. filed an 8-K on July 15, 2025, reporting on matters submitted to a vote of security holders as of July 11, 2025. The filing details the company's corporate structure, including its state of incorporation (Delaware) and principal executive offices in Princeton, New Jersey.
Why It Matters
This 8-K filing indicates that Y-mAbs Therapeutics, Inc. has held or is holding a vote of its security holders, which could pertain to significant corporate decisions or changes.
Risk Assessment
Risk Level: low — This filing is procedural and reports on a vote of security holders, not a material event like a merger or financial distress.
Key Players & Entities
- Y-mAbs Therapeutics, Inc. (company) — Registrant
- July 11, 2025 (date) — Date of earliest event reported
- July 15, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Princeton, New Jersey (location) — Principal executive offices
FAQ
What specific matters were submitted for a vote of Y-mAbs Therapeutics, Inc. security holders?
The filing states that the report is pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and concerns 'Submission of Matters to a Vote of Security Holders,' but the specific details of the vote are not provided in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated July 11, 2025.
What is the principal business address of Y-mAbs Therapeutics, Inc.?
The principal executive offices are located at 202 Carnegie Center Drive, Suite 301, Princeton, New Jersey 08540.
What is the SEC file number for Y-mAbs Therapeutics, Inc.?
The SEC file number for Y-mAbs Therapeutics, Inc. is 001-38650.
What is the SIC code for Y-mAbs Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Y-mAbs Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 15, 2025 regarding Y-mAbs Therapeutics, Inc..